QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Clinical trial NCT03329248 · TERMINATED
Trial details
- NCT number
- NCT03329248
- Sponsor
- ImmunityBio, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-06
- Primary completion
- 2018-08-13
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.